tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Flaten, 72 are a BUY (96%), 3 are a HOLD (4%).
Analyst Thomas Flaten, currently employed at LAKE STREET, carries an average stock price target met ratio of 40.92% that have a potential upside of 55.95% achieved within 155 days.
Thomas Flaten’s has documented 142 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AQST, Aquestive Therapeutics at 07-Mar-2024.
Analyst best performing recommendations are on ENSC (ENSYSCE BIOSCIENCES).
The best stock recommendation documented was for ENSC (ENSYSCE BIOSCIENCES) at 12/1/2021. The price target of $960 was fulfilled within 8 days with a profit of $607.2 (172.11%) receiving and performance score of 215.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$11
$6.71 (156.41%)
$11
3 months 8 days ago
(15-Aug-2024)
0/6 (0%)
$6.55 (147.19%)
Buy
11 months 11 days ago
(12-Dec-2023)
1/1 (100%)
$-45.93 (-79.19%)
189
Buy
$19
$14.71 (342.89%)
$31
1 years 5 months 23 days ago
(31-May-2023)
0/3 (0%)
$12.8 (206.45%)
What Year was the first public recommendation made by Thomas Flaten?
